老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

57.99
+2.274.07%
盘后：58.010.0200+0.03%19:59 EDT
成交量：180.15万
成交额：1.05亿
市值：55.66亿
市盈率：-8.96
高：59.16
开：57.35
低：57.05
收：55.72
52周最高：78.48
52周最低：33.03
股本：9,598.53万
流通股本：9,053.30万
量比：1.06
换手率：1.99%
股息：- -
股息率：- -
每股收益(TTM):-6.4700
每股收益(LYR):-6.4700
净资产收益率：-30.18%
总资产收益率：-15.76%
市净率：2.90
市盈率(LYR):-8.96

数据加载中...

总览公司新闻资讯公告
2020/09/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/27

重要事件披露

8-K - Current report
2020/07/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/02

重要事件披露

8-K - Current report
2020/06/12

重要事件披露

8-K - Current report
2020/06/12

重要事件披露

8-K - Current report
2020/05/14

重要事件披露

8-K - Current report
2020/05/11

重要事件披露

Current report, items 7.01 and 9.01
2020/04/28

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

重要事件披露

Current report, items 2.02 and 9.01
2020/03/31

重要事件披露

Current report, item 8.01
2020/02/26

重要事件披露

8-K - Current report
2020/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
更多